A Lower Serum Antioxidant Capacity as a Distinctive Feature for Women with HER2+ Breast Cancer: A Preliminary Study

A Lower Serum Antioxidant Capacity as a Distinctive Feature for Women with HER2+ Breast Cancer: A Preliminary Study

The overexpression of HER2 in breast cancer (BC) can contribute to redox imbalance, which is related to damage and structural modification in many biomolecules. To the best of our knowledge, this is the first study that has investigated the infrared spectrum wavenumbers obtained by ATR-FTIR and thei...

Full description

Bibliographic Details
Main Authors: Letícia L. D. Santos, Alinne T. F. Silva, Izabella C. C. Ferreira, Adriele V. Souza, Allisson B. Justino, Donizeti W. Santos, Luiz Ricardo Goulart, Carlos Eduardo Paiva, Foued S. Espíndola, Yara C. P. Maia
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Cancers
Subjects:
breast cancer
HER2
redox status markers
antioxidant capacity
FRAP
FTIR
Online Access:https://www.mdpi.com/2072-6694/14/23/5973

Similar Items

Similar Items